GILD
Gilead Sciences, Inc.
Stock
$149.05−2.23 (−1.47%)Close Sep 30, 2026
| Cash and short-term investments (Q4 2022) | YoY | 5-year CAGR | 10-year CAGR |
|---|---|---|---|
| $6.4B | −2.1% | −24.2% | 13.1% |
| Cash and short-term investments (Q4 2022) | $6.4B |
|---|---|
| YoY | −2.1% |
| 5-year CAGR | −24.2% |
| 10-year CAGR | 13.1% |
Cash and short-term investments
| Period | Cash | YoY |
|---|---|---|
| 2022 | $6.4B | −2.1% |
| 2021 | $6.5B | −12.0% |
| 2020 | $7.4B | −69.6% |
| 2019 | $24.4B | −19.1% |
| 2018 | $30.1B | +17.9% |
| 2017 | $25.5B | +114.5% |
| 2016 | $11.9B | −18.6% |
| 2015 | $14.6B | +44.2% |
| 2014 | $10.1B | +375.0% |
| 2013 | $2.1B | +14.5% |
| 2012 | $1.9B | −81.2% |
| 2011 | $9.9B | +371.7% |
| 2010 | $2.1B | +26.7% |
| 2009 | $1.7B | −7.4% |
| 2008 | $1.8B | +84.9% |
| 2007 | $968M | — |